<?xml version="1.0" encoding="UTF-8"?>
<results title="funder">
 <result pre="trials conducted in the late 1990s that served as the" exact="basis" post="for approval of zanamivir and oseltamivir in 1999 and,"/>
 <result pre="Immunization Practices (ACIP)MMWR Recomm Rep201160112421248682 3.Hay AJ et al. Molecular" exact="basis" post="of resistance of influenza A viruses to amantadine. J"/>
 <result pre="related agentsAntimicrobial therapy and vaccines1999Baltimore, MDWilliams and Wilkins134465 18.BelsheRBet al.Genetic" exact="basis" post="of resistance to rimantadine emerging during treatment of influenza"/>
 <result pre="of influenza virus resistance to neuraminidase inhibitorsVirus Res20041031–219920310.1016/j.virusres.2004.02.03415163510 113.CollinsPJet al.Structural" exact="basis" post="for oseltamivir resistance of influenza virusesVaccine2009274563172310.1016/j.vaccine.2009.07.01719840667 114.SamsonMet al.Characterization of"/>
 <result pre="experience with intravenous zanamivir under an emergency investigational new drug" exact="program" post="in the United StatesJ Infect Dis20132071196810.1093/infdis/jis63723089591 184.Chan-TackKMet al.Clinical experience"/>
 <result pre="184.Chan-TackKMet al.Clinical experience with intravenous zanamivir under an Emergency IND" exact="program" post="in the United States (2011–2014)Antivir Ther2015205561410.3851/IMP294425667992 185.FraaijPLet al.Evaluation of"/>
</results>
